Stay updated on Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed from the page. This is a metadata update that does not modify study details.
    Difference
    0.1%
    Check dated 2026-03-18T18:06:30.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T16:51:36.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The funding-lapse notice and the prior revision (v3.4.1) were removed.
    Difference
    0.5%
    Check dated 2026-02-11T02:10:11.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Site-wide updates include a government funding status notice and a Revision: v3.4.1, along with the removal of the previous Revision: v3.4.0; these changes do not alter the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-03T22:52:44.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added a glossary toggle to the page and updated QC-related metadata in the Study Record Dates and footer. The previous QC label and older footer phrasing were removed or changed, reflecting a minor metadata/update change.
    Difference
    0.2%
    Check dated 2026-01-27T17:48:26.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    A new page revision label (v3.3.4) was added and the previous revision (v3.3.3) was removed; this appears to be a minor metadata update with no visible impact on the study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-20T15:47:20.000Z thumbnail image

Stay in the know with updates to Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.